Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells

This publication has 22 references indexed in Scilit:

• Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin
  British Journal of Cancer, 1995
• Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• The effects of suramin on human adrenocortical cells in vitro: Suramin inhibits cortisol secretion and adrenocortical cell growth
  Metabolism, 1991
• Use ofm-[¹³¹I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
  Journal of Clinical Endocrinology & Metabolism, 1991
• Suramin in Adrenal Cancer: Modulation of Steroid Hormone Production, Cytotoxicityin Vitro, and Clinical Antitumor Effect*
  Journal of Clinical Endocrinology & Metabolism, 1990
• Diagnosis and treatment of malignant pheochromocytoma with 131I-meta-iodobenzylguanidine: a case report
  Radiotherapy and Oncology, 1990
• Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A
  FEBS Letters, 1989
• Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine
  Annals of Internal Medicine, 1988
• Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin
  European Journal of Biochemistry, 1988
• EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO
  The Lancet, 1985